JHIU
IRWD icon

Janus Henderson Investors US’s Ironwood Pharmaceuticals IRWD Stock Holding History

Janus Henderson Investors US’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$135M Sell
9,463,526
-5,382,288
-36% -$73.6M 0.11% 232
2016
Q4 		$190M Sell
14,845,814
-911,786
-6% -$11.5M 0.16% 174
2016
Q3 		$210M Sell
15,757,600
-1,152,218
-7% -$13.5M 0.18% 164
2016
Q2 		$185M Sell
16,909,818
-2,660,745
-14% -$26M 0.16% 187
2016
Q1 		$179M Buy
19,570,563
+751,131
+4% +$6.2M 0.16% 180
2015
Q4 		$183M Sell
18,819,432
-152,459
-0.8% -$1.47M 0.16% 177
2015
Q3 		$166M Buy
18,971,891
+369,592
+2% +$3.45M 0.15% 184
2015
Q2 		$188M Buy
18,602,299
+828,835
+5% +$9.63M 0.15% 180
2015
Q1 		$238M Buy
17,773,464
+715,255
+4% +$9.38M 0.2% 134
2014
Q4 		$219M Buy
17,058,209
+1,472,297
+9% +$16.9M 0.19% 147
2014
Q3 		$169M Buy
15,585,912
+8,088,817
+108% +$92.6M 0.15% 183
2014
Q2 		$96.3M Buy
7,497,095
+395,394
+6% +$4.3M 0.09% 273
2014
Q1 		$73.3M Buy
7,101,701
+276,531
+4% +$3.11M 0.07% 336
2013
Q4 		$66.4M Buy
6,825,170
+185,510
+3% +$1.67M 0.06% 343
2013
Q3 		$65.9M Buy
6,639,660
+1,158,484
+21% +$11.4M 0.07% 321
2013
Q2 		$45.7M Buy
+5,481,176
New +$66.4M 0.05% 378

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Janus Henderson Investors US's IRWD Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Ironwood Pharmaceuticals (IRWD) stake by 36% in Q1 2017, selling an estimated $73.6M and leaving 9,463,526 shares worth $135M. The position accounts for 0.11% of the portfolio, ranked #232.

Janus Henderson Investors US first reported a position in IRWD in Q2 2013 and has held it in 16 quarters since. The position peaked at $238M in Q1 2015. 162 funds tracked by Wall St. Rank hold IRWD as of Q1 2017.

  • Janus Henderson Investors US held 9,463,526 shares of Ironwood Pharmaceuticals worth $135M as of Q1 2017.
  • Janus Henderson Investors US sold 5,382,288 Ironwood Pharmaceuticals shares in Q1 2017, an estimated $73.6M.
  • Ironwood Pharmaceuticals made up 0.11% of Janus Henderson Investors US's portfolio in Q1 2017, its #232 holding.
  • Janus Henderson Investors US first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Ironwood Pharmaceuticals position peaked at $238M in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.